Lisata Therapeutics, Inc. - Common Stock (LSTA)
Frequently Asked Questions About Lisata Therapeutics, Inc. - Common Stock (LSTA)
Does Lisata Therapeutics have any products currently on the market?
As of now, Lisata Therapeutics is primarily in the research and development phases and does not have any commercially available products. The company is working to advance its therapeutic candidates through clinical trials.
How can individuals learn more about Lisata Therapeutics?
Individuals can learn more about Lisata Therapeutics by visiting their official website, reviewing their press releases, following their social media channels, and attending investor presentations and healthcare conferences where the company participates.
How does Lisata Therapeutics communicate with its investors?
Lisata Therapeutics communicates with its investors through regular press releases, quarterly earnings reports, and investor conferences. The company aims to maintain transparency around its business activities and clinical developments.
How does Lisata Therapeutics ensure its product safety?
Lisata Therapeutics ensures product safety by conducting rigorous preclinical and clinical studies that adhere to regulatory guidelines. This includes thorough testing and monitoring to assess the safety and efficacy of their therapeutic candidates.
What are the key therapeutic areas of focus for Lisata Therapeutics?
Lisata Therapeutics primarily focuses on developing therapies for oncology and autoimmune diseases. The company aims to advance its pharmaceutical pipeline in these areas to provide effective treatments for patients suffering from these serious health conditions.
What clinical trials is Lisata Therapeutics currently conducting?
Lisata Therapeutics is conducting several clinical trials to evaluate the safety and efficacy of its therapeutic candidates. Detailed information about these trials can be found on their website and through clinical trial registries.
What collaborations or partnerships does Lisata Therapeutics have?
Lisata Therapeutics actively seeks collaborations and partnerships with other biotechnology companies, research institutions, and healthcare providers to enhance their research capabilities and accelerate the development of their therapeutic candidates.
What does Lisata Therapeutics, Inc. do?
Lisata Therapeutics, Inc. is a biotechnology company focused on the development of innovative therapies for patients with serious medical conditions. Their primary focus is on advancing treatments that enhance the quality of life for patients, particularly in the fields of oncology and autoimmune diseases.
What impact does Lisata Therapeutics aim to make in the healthcare sector?
Lisata Therapeutics aims to make a significant impact in the healthcare sector by developing innovative therapies that address unmet medical needs, improving patient outcomes, and contributing to advancements in medical science and treatment options.
What is Lisata Therapeutics' mission?
Lisata Therapeutics’ mission is to innovate and deliver impactful therapies that address and meet the significant medical needs of patients suffering from complex healthcare challenges. They are dedicated to improving patient outcomes through their research.
What is the financial outlook for Lisata Therapeutics?
As a publicly traded company, Lisata Therapeutics is focused on maintaining a sustainable financial outlook by managing its cash reserves effectively, pursuing partnerships, and advancing clinical development to enhance its revenue-generating potential in the future.
What is the leadership structure of Lisata Therapeutics?
Lisata Therapeutics' leadership team consists of seasoned professionals with diverse backgrounds in the biotechnology and pharmaceutical sectors. The team includes executives with expertise in drug discovery, clinical development, corporate strategy, and operational management.
What is the ticker symbol for Lisata Therapeutics?
The ticker symbol for Lisata Therapeutics, Inc. is LSTA, and it is traded on the Nasdaq stock exchange. This symbol is used for trading shares of the company on the public market.
What kind of research does Lisata Therapeutics perform?
Lisata Therapeutics conducts cutting-edge research aimed at understanding disease mechanisms and identifying new therapeutic targets. Their research efforts are supported by in-depth scientific studies and collaborations with academic institutions.
What regulatory agencies oversee Lisata Therapeutics?
Lisata Therapeutics is subject to regulation by key agencies such as the U.S. Food and Drug Administration (FDA) and other international regulatory bodies, which oversee the clinical development and approval processes for their therapeutic products.
What stage are Lisata Therapeutics' pipeline candidates in?
Lisata Therapeutics' pipeline candidates are currently in various stages of preclinical and clinical trials. The company is actively engaged in advancing these candidates to develop new therapeutic options that can be brought to market.
When was Lisata Therapeutics founded?
Lisata Therapeutics was founded in 2020, with the goal of developing novel therapeutics that address unmet medical needs in various disease areas. The company has quickly established itself in the biotechnology industry through its innovative approaches.
Where is Lisata Therapeutics headquartered?
Lisata Therapeutics is headquartered in a strategic location that facilitates access to key resources in the biotechnology industry. Their headquarters serves as the central hub for their research and business operations.
Who are the founders of Lisata Therapeutics?
Lisata Therapeutics was founded by a team of experienced professionals in the biotechnology and pharmaceutical fields. The founders possess extensive expertise in drug development, commercialization, and business management in the healthcare sector.
What is the current price of Lisata Therapeutics, Inc. - Common Stock?
The current price of Lisata Therapeutics, Inc. - Common Stock is 4.170
When was Lisata Therapeutics, Inc. - Common Stock last traded?
The last trade of Lisata Therapeutics, Inc. - Common Stock was at 4:00 pm EST on January 21st, 2026
What is the market capitalization of Lisata Therapeutics, Inc. - Common Stock?
The market capitalization of Lisata Therapeutics, Inc. - Common Stock is 252.42M
How many shares of Lisata Therapeutics, Inc. - Common Stock are outstanding?
Lisata Therapeutics, Inc. - Common Stock has 60.53M shares outstanding.